期刊文献+

多西他赛自乳化固体分散体的制备及体外特性研究 被引量:5

Preparation and characteristics in vitro of docetaxel in self-emulsifying solid dispersion
下载PDF
导出
摘要 目的制备多西他赛自乳化固体分散体(DTX-SESD),并考察其体外特性。方法以自乳化辅料和PEG6000为载体制备多西他赛固体分散体,进行溶解度、体外溶出度和稳定性实验,考察不同自乳化辅料、不同制备方法、不同介质对溶出度的影响。并采用差示扫描量热分析、X-射线粉末衍射分析以鉴别药物在载体中的存在状态。结果 DTX-SESD的溶解度和溶出度分别是原料药的约33.8倍和12.5(2 h)倍;自乳化辅料对药物溶出有显著影响;溶剂法和溶剂熔融法制备的自乳化固体分散体溶出度好于熔融法;溶出介质对溶出无显著影响;自乳化固体分散体中药物主要以分子状态存在。结论自乳化固体分散体能显著提高多西他赛的溶解度和溶出度。 Objective To study on the preparation of docetaxel self-emulsifying solid dispersion(DTX-SESD) and its characteristics in vitro. Methods Self-emulsifying solid dispersion of docetaxel was prepared with PEG6000 and other self-emulsifying excipients.The solubility,stability and dissolution experiments were carried out with different self-emulsifying excipients,preparation methods and medias.Differential thermal analysis and powder X-ray diffraction were employed to identify the drug status in carriers.Results The solubility and dissolution of DTX-SESD were respectively 33.8 and 12.5(2 h)folds as those of the drug crude powder.Significant influence of different self-emulsifying excipients was observed on the dissolution of DTX-SESD,and the dissolution of DTX-SESD prepared by the solvent method and solvent-melting method were better than that with the melting method.There were no apparent differences among the dissolution medias.Drugs in DTX-SESD were mainly molecules.Conclusion It can greatly improve the solubility and dissolution of docetaxel with self-emulsifying solid dispersion.
出处 《广东药学院学报》 CAS 2010年第3期221-225,共5页 Academic Journal of Guangdong College of Pharmacy
基金 湖北省科技攻关课题(2007AA301B15)
关键词 多西他赛 固体分散体 自乳化释药系统 溶出度 docetaxel solid dispersion self-emulsifying drug delivery system dissolution
  • 相关文献

参考文献7

  • 1GURSOY R N,BENITA S.Self-emulsifying drug delivery systems(SEDDS) for improved oral delivery of lipophilic drugs[J].Biomed Pharmacother,2004,58(3):173 -182.
  • 2HEO M Y,PIAO Z Z,KIM T W,et al.Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole[J].Arch Pharm Res,2005,28(5):604 -611.
  • 3段玉平,胡启飞.浅谈固体自乳化药物传递系统固体化技术(续)[J].中国制药信息,2009,25(3):8-9. 被引量:1
  • 4TAKIGAWA N,SEGAWA Y,KISHINO D,et al.Clinical and phamacokinetic study of docetaxel in elderly non-smallcell lung cancer patients[J].Cancer Chemother Pharmacol,2004,54(3):230-236.
  • 5FAZIO R,QUATTRINI A,BOLOGNESI A,et al.Docetaxel neuropathy:a distal axonopathy[J].Acta Neuropathol,1999,98(6):651 -653.
  • 6NANNAN P R,HUIAINGM T,VERMORKEN J B,et al.Hypersensitivity reactions to the taxanes paclitaxel and docetaxel[J].Clin Drug Investig,1997,14 (5):4182 -4271.
  • 7陈鹰,陈戈,史琼枝,余爱荣,符旭东,刘辉.多西他赛自微乳化释药系统的研究[J].中国药师,2009,12(11):1507-1510. 被引量:5

二级参考文献8

  • 1Tham YL, Gomezl F, Mohsn S, et al. Clinical response to neoadjuvard docetaxel predicts improved outcome in patients with large locally advanced breast cancers[J]. Breast Cancer Res Tr, 2005, 94: 279- 84.
  • 2Immordino ML, Brusa P, Arpicco S, et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel[J]. J Control Release, 2003, 91(3) :417-429.
  • 3Bardelmeijer HA, Ouwehand M, Buckle T, et al. Low system is exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir[ J ]. Cancer Res, 2002,62 ( 21 ) : 6158-6164.
  • 4Chiou WL, Wu TC, Ma C, et al. Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine: quantitation and role of Pglycoprotein [ J ]. J Clin Oncol, 2002,20 (7) : 1951-1952.
  • 5Chen Y, Li G, Wu XG, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment[ J]. Biological & Pharmaceutical Bulletin,2008,31 (1) :118-125.
  • 6Malingr6 MM, Beijnen JH, Schellens JH. Oral delivery of taxanes [J]. Invest New Drugs, 2001,19(2) :155-162.
  • 7张洪记,丁盛,顾王文,李亚平,陈伶俐.多西他赛脂质体冻干粉的制备及质量评价[J].中国医药工业杂志,2008,39(2):113-116. 被引量:7
  • 8陈鹰,郑庆玲,刘宏,辛华雯.伊曲康唑自乳化释药系统的处方研究[J].中国药学杂志,2008,43(22):1714-1719. 被引量:3

共引文献4

同被引文献78

  • 1张洪瑶,刘妍,唐星.紫杉醇亚微乳注射液在大鼠体内药动学及组织分布研究[J].中国药剂学杂志(网络版),2008(6):377-385. 被引量:5
  • 2杨睿,唐星,黄惠锋.热熔挤出技术提高水飞蓟素溶出度的初步研究[J].中国新药杂志,2005,14(11):1305-1308. 被引量:25
  • 3尤海生,董亚琳,邢建峰,张春玲,王茂义.灯盏乙素在大鼠体内药代动力学及组织分布的研究[J].中国中药杂志,2007,32(16):1688-1692. 被引量:13
  • 4Fasinu P,Pillay V,Ndesendo Valence M K,et al. Diverse approaches for the enhancement of oral drug bioavailability [ J ]. Biopharm Drug Dispos, 2011,32 ( 4 ) : 185- 209.
  • 5Savjani K T, Gajjar A K, Savjani J K. Drug solubility: importance and enhancement techniques [ J/OL ]. ISRN Pharm, 2012,2012 : 195727 [ 2012-11 - 02 ]. http ://www. hindawi, conr/isrn/pharmaceutics.
  • 6Sareen S, Mathew G,Joseph L. hnprovement in solubility of poor water-soluble drugs by solid dispersion [ J ]. Int J Pharm Investig,2012,2( 1 ) :12-17.
  • 7Potluri R H, Bandari S, Jukanti R, et al. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13 [ J ]. Arch Pharm Res ,2011,34( 1 ) :51-57.
  • 8Sinha S, Ali M, Baboota S, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir [ J ]. AAPS Pharm Sci Tech, 2010,11 (2) :518-527.
  • 9Srinarong P, Hamalainen S, Visser M R, et al. Surfaceactive derivative of inulin (Inutec SP1 ) is a superior carrier for solid dispersions with a high drug load [ J ]. J Pharm Sci, 2011,100 ( 6 ) : 2333-2342.
  • 10Duret C, Wauthoz N, Sebti T, et al. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties [ J ]. Int J Pharm, 2012, 428 (1/2) :103-113.

引证文献5

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部